Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1990 1
1992 3
1994 2
1995 3
1996 3
1997 1
1998 2
1999 4
2000 1
2001 2
2002 2
2003 2
2004 3
2006 1
2007 1
2008 2
2009 4
2010 2
2011 2
2012 2
2015 1
2016 1
2017 1
2018 2
2019 2
2020 1
2022 1
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.
Gehrlein A, Udayar V, Anastasi N, Morella ML, Ruf I, Brugger D, von der Mark S, Thoma R, Rufer A, Heer D, Pfahler N, Jochner A, Niewoehner J, Wolf L, Fueth M, Ebeling M, Villaseñor R, Zhu Y, Deen MC, Shan X, Ehsaei Z, Taylor V, Sidransky E, Vocadlo DJ, Freskgård PO, Jagasia R. Gehrlein A, et al. Among authors: von der mark s. Nat Commun. 2023 Apr 12;14(1):2057. doi: 10.1038/s41467-023-37632-4. Nat Commun. 2023. PMID: 37045813 Free PMC article.
In a mouse disease model, intravenous injection of GCase-BS leads to a sustained reduction of glucosylsphingosine and can lower neurofilament-light chain plasma levels. Collectively, these findings demonstrate the potential of GCase-BS for treating GBA1-associated lysosoma …
In a mouse disease model, intravenous injection of GCase-BS leads to a sustained reduction of glucosylsphingosine and can lower neurofilamen …
COVID-19 pandemic stress and cancer symptom burden.
Ballesteros O, Mark S, Block A, Mackin L, Paul S, Cooper B, Abbott M, Chang S, Hammer MJ, Levine J, Pozzar R, Snowberg K, Tsai K, Van Blarigan E, Van Loon K, Miaskowski CA. Ballesteros O, et al. Among authors: mark s. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e1351-e1362. doi: 10.1136/spcare-2023-004319. BMJ Support Palliat Care. 2024. PMID: 37541779
The two worst stress profiles reported clinically meaningful levels of all of the common symptoms associated with cancer and its treatments. ...
The two worst stress profiles reported clinically meaningful levels of all of the common symptoms associated with cancer and its trea …
On design considerations and randomization-based inference for community intervention trials.
Gail MH, Mark SD, Carroll RJ, Green SB, Pee D. Gail MH, et al. Among authors: mark sd. Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q. Stat Med. 1996. PMID: 8804140 Review.
Otherwise, size is likely near nominal levels. To avoid such problems, we recommend use of the same numbers of control and intervention communities in unmatched designs. Pair-matched designs usually have size near nominal levels, even under the weak null hypothesis. …
Otherwise, size is likely near nominal levels. To avoid such problems, we recommend use of the same numbers of control and interventi …
Defining and analyzing health system resilience in rural jurisdictions.
Barnard M, Mark S, Greer SL, Trump BD, Linkov I, Jarman H. Barnard M, et al. Among authors: mark s. Environ Syst Decis. 2022;42(3):362-371. doi: 10.1007/s10669-022-09876-w. Epub 2022 Aug 18. Environ Syst Decis. 2022. PMID: 35996449 Free PMC article.
This Commentary reviews key forms of risk and constructs a county-level index of resilience for the United States which helps to identify countries with limited resilience. Further, it argues that health care resilience should be conceptualized in terms of broader regions …
This Commentary reviews key forms of risk and constructs a county-level index of resilience for the United States which helps to iden …
The rate of platelet activation determines thrombus size and structure at arterial shear.
Mitchell JL, Dunster JL, Kriek N, Unsworth AJ, Sage T, Mohammed YMM, De Simone I, Taylor KA, Bye AP, Ólafsson G, Brunton M, Mark S, Dymott LD, Whyte A, Ruparelia N, Mckenna C, Gibbins JM, Jones CI. Mitchell JL, et al. Among authors: mark s. J Thromb Haemost. 2023 Aug;21(8):2248-2259. doi: 10.1016/j.jtha.2023.03.044. Epub 2023 Apr 19. J Thromb Haemost. 2023. PMID: 37085037 Free article.
Current platelet function tests are used to measure end-point levels of platelet activation without taking the speed at which platelets activate into account, potentially missing vital metrics to characterize platelet reactivity. ...
Current platelet function tests are used to measure end-point levels of platelet activation without taking the speed at which platele …
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI; MGTX study group. Lee I, et al. Neurology. 2020 Aug 11;95(6):e755-e766. doi: 10.1212/WNL.0000000000010031. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611638 Free PMC article. Clinical Trial.
Prednisone-associated adverse symptoms were more frequent in the prednisone alone group and distress level increased with higher doses of prednisone. CONCLUSIONS: Thymectomy benefits patients with MG by increasing the likelihood of achieving sustained MMS with complete wit …
Prednisone-associated adverse symptoms were more frequent in the prednisone alone group and distress level increased with higher dose …
Genome structure predicts modular transcriptome responses to genetic and environmental conditions.
Mark S, Weiss J, Sharma E, Liu T, Wang W, Claycomb JM, Cutter AD. Mark S, et al. Mol Ecol. 2019 Aug;28(16):3681-3697. doi: 10.1111/mec.15185. Epub 2019 Aug 5. Mol Ecol. 2019. PMID: 31325381
The 22 co-expression modules that we identified differ in their enrichment of genes with genetic vs. environmental vs. interaction effects, as well as their genomic spatial distributions, functional attributes and rates of molecular evolution at the sequence level. Genes i …
The 22 co-expression modules that we identified differ in their enrichment of genes with genetic vs. environmental vs. interaction effects, …
Bone marrow transplant in adrenoleukodystrophy.
Moser HW, Tutschka PJ, Brown FR 3rd, Moser AE, Yeager AM, Singh I, Mark SA, Kumar AA, McDonnell JM, White CL 3rd, et al. Moser HW, et al. Among authors: mark sa. Neurology. 1984 Nov;34(11):1410-7. doi: 10.1212/wnl.34.11.1410. Neurology. 1984. PMID: 6387532
The patient died of an adenovirus infection 141 days after BMT. ALD is characterized by abnormally high plasma levels of very long chain fatty acids (VLCFA) as a result of impaired capacity to degrade them. Ten days after BMT, the white blood cell VLCFA levels and e …
The patient died of an adenovirus infection 141 days after BMT. ALD is characterized by abnormally high plasma levels of very long ch …
Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
Sampurno F, Zheng J, Di Stefano L, Millar JL, Foster C, Fuedea F, Higano C, Hulan H, Mark S, Moore C, Richardson A, Sullivan F, Wenger NS, Wittmann D, Evans S. Sampurno F, et al. Among authors: mark s. J Urol. 2018 Aug;200(2):319-326. doi: 10.1016/j.juro.2018.02.071. Epub 2018 Mar 1. J Urol. 2018. PMID: 29477721
These potential indicators were refined and developed through a modified Delphi process during which each panelist independently and repeatedly rated each indicator based on importance (satisfying the indicator demonstrated a provision of high quality care) and feasibility (the l …
These potential indicators were refined and developed through a modified Delphi process during which each panelist independently and repeate …
Prognostic factors in malignant ureteric obstruction.
Lienert A, Ing A, Mark S. Lienert A, et al. Among authors: mark s. BJU Int. 2009 Oct;104(7):938-41. doi: 10.1111/j.1464-410X.2009.08492.x. Epub 2009 Mar 26. BJU Int. 2009. PMID: 19338533
CONCLUSION: Consistent with a previous report we showed that a low serum albumin level and events related to metastatic disease were indicative of a poor prognosis. We also found that a low serum sodium level might be associated with a worse prognosis. We externally …
CONCLUSION: Consistent with a previous report we showed that a low serum albumin level and events related to metastatic disease were …
58 results